Combined Therapeutics Revenue and Competitors
Estimated Revenue & Valuation
- Combined Therapeutics's estimated annual revenue is currently $2.5M per year.
- Combined Therapeutics's estimated revenue per employee is $155,000
Employee Data
- Combined Therapeutics has 16 Employees.
- Combined Therapeutics grew their employee count by -6% last year.
Combined Therapeutics's People
Name | Title | Email/Phone |
---|---|---|
1 | President and co-founder CEO | Reveal Email/Phone |
2 | Managing Director France | Reveal Email/Phone |
3 | Lab Manager | Reveal Email/Phone |
4 | Research Associate, Biology | Reveal Email/Phone |
5 | Associate Scientist | Reveal Email/Phone |
6 | Scientist, Molecular and Cellular Biology | Reveal Email/Phone |
Combined Therapeutics Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $12.7M | 82 | -45% | $107.3M | N/A |
#2 | $0.2M | 1 | -50% | N/A | N/A |
#3 | $6.2M | 40 | 21% | N/A | N/A |
#4 | $14.6M | 94 | -37% | $312.8M | N/A |
#5 | $0.3M | 2 | -67% | N/A | N/A |
#6 | $235M | 366 | -5% | $340.9M | N/A |
#7 | $56M | 289 | -7% | $7.6M | N/A |
#8 | $4.7M | 61 | 36% | N/A | N/A |
#9 | $2M | 13 | 8% | N/A | N/A |
#10 | $5.4M | 35 | 0% | N/A | N/A |
What Is Combined Therapeutics?
CTx is an early stage startup developing the second generation of therapeutic & intelligent mRNA. Thanks to its delivery and modulation platform, CTx is killing cancer cells and is sparing healthy cells. CTx is located in Cambridge (USA) and London (UK).
keywords:N/AN/A
Total Funding
16
Number of Employees
$2.5M
Revenue (est)
-6%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $0.5M | 16 | -16% | $7.1M |
#2 | $3.5M | 16 | -6% | N/A |
#3 | $1M | 16 | N/A | N/A |
#4 | $1.4M | 16 | N/A | N/A |
#5 | $1M | 16 | 7% | N/A |